|
Market Cap (5-Jun) $13,719,451 (1,617th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 431,146 |
Shortsold (21-Jul) 380,000 (0.14%) (384th) |
|
52w High $0.098 |
52w Low $0.026 |
P/E - |
EPS -0.02 |
IMC released this announcement to the ASX on 28 February 2023, 19:03. The announcement is marked as price sensitive, and is 35 page(s) in length and 2.8MB in size.
You can view all announcements from IMC and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMC was 0.002% short sold according to ASIC data. It was ranked the 616th most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.142% of total shares short sold as of the latest reported data (21 July 2025).
| Other Recent Announcements from IMC | |
|---|---|
| Immuron Chairman Transition | 30 June 2023, 11:03 |
| Letter to Shareholders | 22 June 2023, 8:27 |
| Immuron CEO, Steven Lydeamore presents at LD Micro | 7 June 2023, 8:26 |
| Appendix 4D and Half Year Report | 28 February 2023, 19:03 |
| Business Update Presentation | 28 February 2023, 9:45 |
| Immuron CEO Steven Lydeamore to host investor webinar | 15 February 2023, 8:04 |
| Immuron and US NMRC respond to CampETEC FDA Clinical Hold | 25 January 2023, 9:30 |
You must be logged in to post a reply.
Immuron 